|
CAS No:137525-51-0
1:PN: CN1296079 PAGE: 1 claimed sequence BPC (body protection compound) BPC157
|
|
CAS No:221231-10-3
LIPOTROPIN High purity and high activity AOD 9604 AOD 9604 High purity 99%
|
|
CAS No:129954-34-3
High purity and high activity Selank(SK5,10,30) High purity and high activity99%Selank(SK5,10,30) Selank(SK5,10,30)
|
|
CAS No:1627580-64-6
Mots-c UNII-A5CV6JFB78 1627580-64-6
|
|
CAS No:885340-08-9
TB500 885340-08-9 UNII-QHK6Z47GTG
|
|
CAS No:863288-34-0
CJC-1295 without DAC 10mg + IPA 10mg high-quality High purity and high activity CJC1295 without DAC 10mg + IPA 10mg CJC1295 without DAC 10mg + IPA 10mg
|
|
CAS No:49557-75-7
KL80 KL80 High quality, high purity 99% KL80Highly active peptides
|
|
CAS No:49557-75-7
Semax(XA5 XA10 XA30) High quality, high purity 99% Semax Highly active peptides
|
|
CAS No:62568-57-4
11:PN: US20070269902 SEQID: 11 unclaimed sequence 1261: PN: US20090175821 SEQID:1547 claimed protein 1: PN: US20090142851 SEQID: 1 claimed protein
|
|
CAS No:34973-08-5
Luprolite acetate peptide wholesale
|
|
CAS No:1607799-13-2
bremelanotide PT-141 Vyleesi
|
|
CAS No:121062-08-6
L-Lysinamide,N-acetyl-L-norleucyl-L-a-aspartyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophyl-, cyclic (2? 1,4,7,10,13,18-Hexaazacyclotricosane, cyclic peptide deriv. 17: PN:WO2006012667 PAGE: 40 claimed protein
|
|
CAS No:75921-69-6
alpha-Msh, nle(4)-phe(7)- alpha-Msh, norleucyl(4)-D-phenylalanyl(7)- (Nle4,D-Phe7)-alpha-MSH
|
|
CAS No:137525-51-0
1:PN: CN1296079 PAGE: 1 claimed sequence BPC (body protection compound) BPC157
|
|
CAS No:67727-97-3
KPV
|
|
CAS No:40077-57-4
VIP
|
|
CAS No:53-84-9
NAD+
|
|
CAS No:2460055-10-9
FOXO4
|
|
CAS No:1627580-64-6
MOTS-c
|
|
CAS No:946870-92-4
IGF-1LR3
|
